gallopamil has been researched along with Arrhythmia in 19 studies
Gallopamil: Coronary vasodilator that is an analog of iproveratril (VERAPAMIL) with one more methoxy group on the benzene ring.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The antiarrhythmic effects of gallopamil on adrenaline-, digitalis- and two-stage coronary ligation-induced arrhythmias and on adrenaline-induced triggered arrhythmia were investigated." | 7.68 | Effects of gallopamil, a Ca2+ channel blocker in models of ventricular arrhythmia in dogs. ( Haruno, A; Hashimoto, K; Matsuzaki, T, 1993) |
| "The comparative effects of the calcium-antagonists gallopamil and nifedipine on ischemia-induced and reperfusion-induced ventricular arrhythmias, particularly ventricular fibrillation (VF), were assessed in a total of 40 mongrel dogs in two experimental preparations." | 7.67 | Calcium antagonists and acute myocardial ischemia: comparative effects of gallopamil and nifedipine on ischemia-induced and reperfusion-induced ventricular arrhythmias, epicardial conduction times, and ventricular fibrillation thresholds. ( Bender, F; Gülker, H; Haverkamp, W; Hindricks, G, 1987) |
| "In intact rats, as well as in isolated perfused rat hearts, the calcium antagonist gallopamil reduced the severity of ischemic and reperfusion-induced arrhythmias." | 7.67 | The effect of the calcium antagonist gallopamil on arrhythmias and enzyme release in rat hearts with coronary ligation and reperfusion. ( Bernauer, W, 1987) |
| "For effective treatment of coronary heart disease with calcium antagonists, knowledge of both the dose-response relationship of a remedy and equipotent dosage for comparison of different drugs is necessary." | 6.66 | [Dose-response relation of gallopamil in comparison with nifedipine, diltiazem and tiapamil in patients with coronary heart disease]. ( Fleischer, K; Forster, A; Hopf, R; Kaltenbach, M; Mohler, C; Schulz, PC, 1989) |
| "Triggered arrhythmias in rat right ventricular trabeculae are induced by triggered propagated contractions (TPCs) that start in damaged regions of the muscle and propagate along the preparation." | 5.28 | Suppressive effects of R 56865 on triggered propagated contractions and triggered arrhythmias in rat cardiac trabeculae. ( Daniels, MC; ter Keurs, HE, 1992) |
| "Reentrant ventricular arrhythmias (RVA) were analyzed in dogs 3--7 days after ligation of the anterior descending coronary artery using averaged "composite" recordings of electrical activity of reentrant pathways (RP) from the epicardial surface of the infarction zone (IZ)." | 5.26 | Reentrant ventricular arrhythmias in the late myocardial infarction period. 7. Effect of verapamil and D-600 and the role of the "slow channel". ( El-Sherif, N; Lazzara, R, 1979) |
| "The antiarrhythmic effects of gallopamil on adrenaline-, digitalis- and two-stage coronary ligation-induced arrhythmias and on adrenaline-induced triggered arrhythmia were investigated." | 3.68 | Effects of gallopamil, a Ca2+ channel blocker in models of ventricular arrhythmia in dogs. ( Haruno, A; Hashimoto, K; Matsuzaki, T, 1993) |
| "The comparative effects of the calcium-antagonists gallopamil and nifedipine on ischemia-induced and reperfusion-induced ventricular arrhythmias, particularly ventricular fibrillation (VF), were assessed in a total of 40 mongrel dogs in two experimental preparations." | 3.67 | Calcium antagonists and acute myocardial ischemia: comparative effects of gallopamil and nifedipine on ischemia-induced and reperfusion-induced ventricular arrhythmias, epicardial conduction times, and ventricular fibrillation thresholds. ( Bender, F; Gülker, H; Haverkamp, W; Hindricks, G, 1987) |
| "In intact rats, as well as in isolated perfused rat hearts, the calcium antagonist gallopamil reduced the severity of ischemic and reperfusion-induced arrhythmias." | 3.67 | The effect of the calcium antagonist gallopamil on arrhythmias and enzyme release in rat hearts with coronary ligation and reperfusion. ( Bernauer, W, 1987) |
| " Twenty-four-hour Holter monitoring, exercise testing, and adverse effects were controlled at days 7, 14, and 21." | 2.67 | Exercise-induced symptomatic and asymptomatic myocardial ischemia in patients with severe coronary artery disease: focus on the efficacy and safety of gallopamil. ( Hohnloser, S; Just, H; Kosscheck, U; Meinertz, T; Weiss, C; Zehender, M, 1992) |
| "For effective treatment of coronary heart disease with calcium antagonists, knowledge of both the dose-response relationship of a remedy and equipotent dosage for comparison of different drugs is necessary." | 2.66 | [Dose-response relation of gallopamil in comparison with nifedipine, diltiazem and tiapamil in patients with coronary heart disease]. ( Fleischer, K; Forster, A; Hopf, R; Kaltenbach, M; Mohler, C; Schulz, PC, 1989) |
| "Severe adverse effects associated with the use of calcium channel blockers do not occur very often." | 2.38 | [The spectrum of side effects of gallopamil in comparison with other calcium antagonists]. ( Hopf, R; Kaltenbach, M; Klepzig, H; Mildenberger, D, 1989) |
| "The same type of arrhythmia was observed combining low concentrations of mibefradil with amlodipine, or with gallopamil, respectively." | 1.31 | Pharmacodynamic interaction between mibefradil and other calcium channel blockers. ( Antepohl, W; Haaf, O; Herzig, S; Huber, I; Matthes, J; Striessnig, J, 2000) |
| "TTX and nicorandil decreased arrhythmias, probably by decreasing the Na+ current or by increasing the ATP-sensitive K+ current, respectively." | 1.29 | Prevention of reoxygenation-induced arrhythmias in guinea pig papillary muscles. ( Hayashi, H; Katoh, H; McDonald, TF; Terada, H, 1996) |
| "Triggered arrhythmias in rat right ventricular trabeculae are induced by triggered propagated contractions (TPCs) that start in damaged regions of the muscle and propagate along the preparation." | 1.28 | Suppressive effects of R 56865 on triggered propagated contractions and triggered arrhythmias in rat cardiac trabeculae. ( Daniels, MC; ter Keurs, HE, 1992) |
| "Reentrant ventricular arrhythmias (RVA) were analyzed in dogs 3--7 days after ligation of the anterior descending coronary artery using averaged "composite" recordings of electrical activity of reentrant pathways (RP) from the epicardial surface of the infarction zone (IZ)." | 1.26 | Reentrant ventricular arrhythmias in the late myocardial infarction period. 7. Effect of verapamil and D-600 and the role of the "slow channel". ( El-Sherif, N; Lazzara, R, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (63.16) | 18.7374 |
| 1990's | 6 (31.58) | 18.2507 |
| 2000's | 1 (5.26) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bender, F | 3 |
| Nathan, RD | 1 |
| Bhattacharyya, ML | 1 |
| Schlepper, M | 1 |
| Hisatome, I | 1 |
| Arita, M | 1 |
| Matsuzaki, T | 1 |
| Haruno, A | 1 |
| Hashimoto, K | 1 |
| Hayashi, H | 1 |
| Terada, H | 1 |
| Katoh, H | 1 |
| McDonald, TF | 1 |
| Matthes, J | 1 |
| Huber, I | 1 |
| Haaf, O | 1 |
| Antepohl, W | 1 |
| Striessnig, J | 1 |
| Herzig, S | 1 |
| El-Sherif, N | 1 |
| Lazzara, R | 1 |
| Danilenko, AM | 1 |
| Siianov, VS | 1 |
| Rodionov, VM | 1 |
| Fialko, VA | 1 |
| Zehender, M | 1 |
| Kosscheck, U | 1 |
| Hohnloser, S | 1 |
| Weiss, C | 1 |
| Meinertz, T | 1 |
| Just, H | 1 |
| Daniels, MC | 1 |
| ter Keurs, HE | 1 |
| Kirchengast, M | 1 |
| Hergenröder, S | 1 |
| Reiterer, W | 1 |
| Mildenberger, D | 1 |
| Klepzig, H | 1 |
| Hopf, R | 2 |
| Kaltenbach, M | 2 |
| Fleischer, K | 1 |
| Forster, A | 1 |
| Mohler, C | 1 |
| Schulz, PC | 1 |
| Loskot, F | 1 |
| Novotny, P | 1 |
| Sucic, P | 1 |
| Schneider, G | 1 |
| Gülker, H | 1 |
| Haverkamp, W | 1 |
| Hindricks, G | 1 |
| Bernauer, W | 1 |
1 review available for gallopamil and Arrhythmia
| Article | Year |
|---|---|
[The spectrum of side effects of gallopamil in comparison with other calcium antagonists].
Topics: Arrhythmias, Cardiac; Calcium Channel Blockers; Gallopamil; Humans; Myocardial Contraction; Structur | 1989 |
5 trials available for gallopamil and Arrhythmia
| Article | Year |
|---|---|
Clinical uses of calcium ion antagonists in arrhythmias.
Topics: Adult; Aged; Alprenolol; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium; Child, Preschool; Cl | 1980 |
Hemodynamic effects in patients with cardiac arrhythmias.
Topics: Arrhythmias, Cardiac; Blood Pressure; Clinical Trials as Topic; Digitalis Glycosides; Gallopamil; He | 1980 |
Exercise-induced symptomatic and asymptomatic myocardial ischemia in patients with severe coronary artery disease: focus on the efficacy and safety of gallopamil.
Topics: Aged; Arrhythmias, Cardiac; Circadian Rhythm; Coronary Disease; Electrocardiography; Electrocardiogr | 1992 |
[Dose-response relation of gallopamil in comparison with nifedipine, diltiazem and tiapamil in patients with coronary heart disease].
Topics: Adult; Aged; Angina Pectoris; Arrhythmias, Cardiac; Calcium Channel Blockers; Clinical Trials as Top | 1989 |
[Therapeutic coronary effectiveness of retard gallopamil following repeated administration in comparison with placebo].
Topics: Administration, Oral; Adult; Aged; Angina Pectoris; Arrhythmias, Cardiac; Coronary Disease; Delayed- | 1989 |
13 other studies available for gallopamil and Arrhythmia
| Article | Year |
|---|---|
[Treatment of heart arrhythmias with calcium antagonists].
Topics: Arrhythmias, Cardiac; Atrioventricular Node; Calcium Channel Blockers; Cardiac Complexes, Premature; | 1984 |
Perturbations in the membrane potential of cultured heart cells: role of calcium.
Topics: Animals; Arrhythmias, Cardiac; Caffeine; Calcimycin; Calcium; Cells, Cultured; Chick Embryo; Diastol | 1984 |
Effects of catecholamines on the residual sodium channel dependent slow conduction in guinea pig ventricular muscles under normoxia and hypoxia.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Calcium Channels; Catecholamines; Dose-Response Re | 1995 |
Effects of gallopamil, a Ca2+ channel blocker in models of ventricular arrhythmia in dogs.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Disease Models, Animal; Dogs; | 1993 |
Prevention of reoxygenation-induced arrhythmias in guinea pig papillary muscles.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium; Gallopamil; Guine | 1996 |
Pharmacodynamic interaction between mibefradil and other calcium channel blockers.
Topics: Amlodipine; Animals; Arrhythmias, Cardiac; Calcium Channel Blockers; Calcium Channels, L-Type; Cell | 2000 |
Reentrant ventricular arrhythmias in the late myocardial infarction period. 7. Effect of verapamil and D-600 and the role of the "slow channel".
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Coronary Disease; Dogs; Electrocardiography; Gallo | 1979 |
[Use of panangin, obsidan and isoptin in acute rhythm disorders under conditions of cardiological first aid service].
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Aspartic Acid; | 1976 |
Suppressive effects of R 56865 on triggered propagated contractions and triggered arrhythmias in rat cardiac trabeculae.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Benzothiazoles; Calcium; Calcium Channel Blockers; | 1992 |
Reperfusion arrhythmias in closed-chest rats: the effect of myocardial noradrenaline depletion and Ca2(+)-antagonism.
Topics: Animals; Arrhythmias, Cardiac; Blood Pressure; Coronary Disease; Gallopamil; Heart Ventricles; Male; | 1991 |
[Exercise capacity of coronary heart disease patients in long-term follow-up with gallopamil in comparison with premedication with verapamil].
Topics: Aged; Angina Pectoris; Arrhythmias, Cardiac; Coronary Disease; Electrocardiography; Exercise Test; F | 1989 |
Calcium antagonists and acute myocardial ischemia: comparative effects of gallopamil and nifedipine on ischemia-induced and reperfusion-induced ventricular arrhythmias, epicardial conduction times, and ventricular fibrillation thresholds.
Topics: Animals; Arrhythmias, Cardiac; Blood Pressure; Calcium Channel Blockers; Coronary Disease; Dogs; Fem | 1987 |
The effect of the calcium antagonist gallopamil on arrhythmias and enzyme release in rat hearts with coronary ligation and reperfusion.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Circulation; Coronary Disease; Creat | 1987 |